Coronavirus (COVID-19) Resource Center

Overview

This Resource Center provides guidance and addresses questions about legal and business concerns arising from the Coronavirus (COVID-19).

A cross-disciplinary team of BakerHostetler attorneys publish useful information about the fast-changing environment and about actions businesses may, or must, lawfully take to address a number of issues to protect employees and business operations.

We are committed to providing companies with consistent, frequent and transparent communication regarding COVID-19.

Should you have any questions, please feel free to contact any of our attorneys to help navigate you through this global medical crisis.

Return-to-Work Toolkit

The CARES Act

Prior Communications: April | March

CARES Act SWAT Team

Tax
Labor and Employment
Business
Litigation

Business Restructuring Response Team

Debt Finance
Restructuring and Bankruptcy

Latest Communications

Advertising Energy Labor and Employment
Antitrust Environmental Litigation
Bankruptcy and Restructuring FDA M&A
Commercial Contracts Federal Policy Private Wealth
Commercial Litigation Government Contracts Real Estate
Compliance Healthcare Securities

Corporate Governance

Information Governance Tax
Debt Finance Intellectual
Property
White Collar
Digital Assets and Data Management International Trade Who To Contact
Employee Benefits Investment Funds Additional Resources

Advertising
Prior Communications: March

Top of Page

Antitrust
Prior Communications: MayApril | March

Top of Page

Bankruptcy and Restructuring
Prior Communications: April

Top of Page

Commercial Contracts

Top of Page

Commercial Litigation

Top of Page

Compliance

Top of Page

Corporate Governance

Prior Communications: March

Top of Page

Debt Finance
Prior Communications: MayAprilMarch

Top of Page

Digital Asset and Data Management
Prior Communications: MayApril | March

Top of Page

Employee Benefits
Prior Communications: JuneMayApril | March

Top of Page

Energy
Prior Communications: March
Top of Page
Environmental
Prior Communications: March

Top of Page

FDA

May 11, 2020 FDA and State Boards of Pharmacy React to COVID-19 – May 11, 2020 Update

Prior Communications: April | March

Top of Page

Federal Policy
Prior Communications: AprilMarch
Top of Page
Government Contracts
Prior Communications: March

Top of Page

Healthcare
Prior Communications: April | March

Top of Page

Information Governance

Top of Page

Intellectual Property
Prior Communications: JuneMayAprilMarch

Top of Page

International Trade
Prior Communications: March

Top of Page

Investment Funds
Prior Communications: March

Top of Page

Labor and Employment
Prior Communications: JuneMayApril | March

Top of Page

Litigation
Prior Communications: April | March

Top of Page

M&A

Top of Page

Private Wealth
Prior Communications: May | April | March

Top of Page

Real Estate
Prior Communications: MayApril | March

Top of Page

Securities
Prior Communications: MayApril | March

Top of Page

Tax
Prior Communications: MayApril | March

Top of Page

White Collar
Prior Communications: April | March

Top of Page

FAQs

COVID-19 Webinar Series

Webinar Recordings


Who to Contact

Antitrust

Bankruptcy and
Restructuring
Business and Corporate
Commercial Contracts
Debt Finance
E-Discovery Advocacy
and Management
Election Law2
Employee Benefits
Energy Industry
FDA
Federal Policy
Healthcare Industry
Hospitality Industry
Insurance Coverage
International Disputes
Labor and Employment
Litigation
Privacy
Real Estate
Tax
White Collar/
Corporate Investigations
Top of Page

Additional Resources

Top of Page

Professionals

Name Title Office Email
Counsel Cleveland
Partner Columbus
Partner New York
Partner Cleveland
Partner New York
Partner Costa Mesa
Partner Washington, D.C.
Partner Houston
Senior Advisor Washington, D.C.
Partner Chicago
Partner Cleveland
Partner Cleveland
Partner New York
Partner Orlando
Partner Orlando
Counsel Columbus
Partner Cleveland
Partner Cleveland
Partner Los Angeles
Partner New York
Senior Advisor Washington, D.C.
Partner Los Angeles
Partner Washington, D.C.
Partner Washington, D.C.
Partner Houston
Partner Washington, D.C.
Partner Atlanta
Partner Orlando
Partner Cleveland
Partner Los Angeles
Partner Washington, D.C.
Partner Denver
Partner Washington, D.C.
Partner New York
Partner Washington, D.C.
Counsel Denver
Of Counsel Philadelphia
Partner Houston
Partner Washington, D.C.
Partner New York
Partner Cleveland
Partner Washington, D.C.
Partner Dallas
Partner New York
Partner Houston

News

News

Publications

Alerts

Articles

Videos

Blog Posts

Events

Key Contacts

Blog

In The Blogs

Previous Next
IP Intelligence: Insight on Intellectual Property
‘Something of an Experiment': District of Delaware Prepares for Socially Distanced Patent Trial Tentatively Set for August 2020
By Andrew E. Samuels
July 6, 2020
In an earlier blog post, we commented on how the COVID-19 pandemic has affected and may continue to affect patent litigation. A recent order from one of the country’s busiest patent courts, the District of Delaware, reflects the ways in...
Read More ->
Data Counsel
CPRA Moves Forward Despite COVID-19 Woes
By Taylor A. Bloom, Kyle R. Fath
June 24, 2020
On Friday, June 19, the Superior Court of California issued a ruling that paved the way for Californians to see the California Privacy Rights Act (CPRA) on the ballot in November. In its ruling, the court recognized that Alastair...
Read More ->
IP Intelligence: Insight on Intellectual Property
USPTO Grants Relief for Patent Applicants Who Failed to Timely File Patent Applications Due to the COVID-19 Outbreak
By Fabian M. Koenigbauer
June 18, 2020
The United States Patent and Trademark Office (USPTO) has again exercised its authority under the Coronavirus Aid, Relief, and Economic Security Act to grant patent applicants additional COVID-19 outbreak-related relief. In addition to the...
Read More ->
IP Intelligence: Insight on Intellectual Property
Fast-Track Examination for COVID-19-Related Trademarks and Service Marks
By Lisa Bollinger Gehman
June 16, 2020
The U.S. Patent and Trademark Office (USPTO) issued a notice on June 12 announcing a new, accelerated examination program for certain COVID-19-related trademark applications. The USPTO will begin accepting petitions for fast-track...
Read More ->
IP Intelligence: Insight on Intellectual Property
The Potential Patent Risks Associated with COVID-19 Collaborations
By Fabian M. Koenigbauer
June 15, 2020
As researchers at universities and pharmaceutical companies rush to find treatments for COVID-19, new potential patent risks arise. While owners of existing patents that may be useful for COVID-19 treatments may have agreed to free up...
Read More ->